Zealand Pharma A/S banner

Wall St Price Targets

ZEAL Price Forecast
Based on 17 analysts

+66% Upside
from kr231 today

Zealand Pharma A/S (ZEAL)’s 12-month stock price forecast through November 2027 has a consensus target of kr382.5, implying 66% upside. The forecast is based on price targets from 17 Wall Street analysts.

ZEAL Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for ZEAL yet.

Zealand Pharma A/S Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ZEAL's stock price target?
Price Target
382.5 DKK

According to Wall Street analysts, the average 1-year price target for ZEAL is 382.5 DKK with a low forecast of 292.9 DKK and a high forecast of 787.5 DKK.

What is the Revenue forecast for Zealand Pharma A/S?
Projected CAGR
-7%

Over the last 13 years, the compound annual growth rate for Revenue has been 33%. The projected CAGR for the next 8 years is -7%.

What is the Gross Profit forecast for Zealand Pharma A/S?
Projected CAGR
-64%

The compound annual growth rate for Gross Profit over the next 3 years is -64%.

What is the Operating Income forecast for Zealand Pharma A/S?
Projected CAGR
-18%

Over the last 13 years, the compound annual growth rate for Operating Income has been 51%. The projected CAGR for the next 8 years is -18%.

Back to Top